Fusion Antibodies (FAB) Stock Chart & Stock Price History GBX 6.39 +0.24 (+3.90%) As of 12:10 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock Fusion Antibodies Stock Price Performance 5 Day Performance-3.47%1 Month Performance-20.13%3 Month Performance-10.75%6 Month Performance+53.98%Year-To-Date Performance-10.75%1 Year Performance+70.40% Receive FAB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Fusion Antibodies and its competitors with MarketBeat's FREE daily newsletter. Email Address FAB Stock Chart for Tuesday, April, 1, 2025 FAB Chart by TradingViewRemove Ads Fusion Antibodies Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/01/2025GBX 6.20GBX 6.39+3.06%GBX 6.50GBX 62.29 million shs£6.01 million03/31/2025GBX 6.62GBX 6.20-6.34%GBX 6.62GBX 61.22 million shs£5.83 million03/28/2025GBX 6.62GBX 6.62GBX 6.62GBX 6.24105,290 shs£6.23 million03/27/2025GBX 6.67GBX 6.62-0.75%GBX 6.67GBX 6.26571,380 shs£6.23 million03/26/2025GBX 6.67GBX 6.67GBX 6.70GBX 6.30369,974 shs£6.27 million03/25/2025GBX 6.40GBX 6.67+4.22%GBX 6.80GBX 6.152.00 million shs£6.27 million03/24/2025GBX 6.70GBX 6.40-4.48%GBX 6.90GBX 62.04 million shs£6.02 million03/21/2025GBX 6.70GBX 6.70GBX 6.90GBX 6.3674,753 shs£6.30 million03/20/2025GBX 6.80GBX 6.70-1.47%GBX 6.75GBX 6.33482,761 shs£6.30 million03/19/2025GBX 6.37GBX 6.80+6.75%GBX 6.90GBX 6.501.69 million shs£6.40 million Get the Latest News and Ratings for FAB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Fusion Antibodies and its competitors with MarketBeat's FREE daily newsletter. 03/18/2025GBX 6.57GBX 6.37-2.97%GBX 7GBX 6.223.65 million shs£5.99 million03/17/2025GBX 7GBX 6.57-6.21%GBX 7GBX 6.21783,776 shs£6.18 million03/14/2025GBX 6.97GBX 7+0.43%GBX 7GBX 6.521.17 million shs£6.58 million03/13/2025GBX 7GBX 6.97-0.43%GBX 7.16GBX 6.80734,953 shs£6.56 million03/12/2025GBX 7.50GBX 7-6.67%GBX 7.49GBX 6.821.23 million shs£6.58 million03/11/2025GBX 8.19GBX 7.50-8.37%GBX 8.19GBX 7.231.22 million shs£7.05 million03/10/2025GBX 8GBX 8.19+2.31%GBX 8.50GBX 7.60420,337 shs£7.70 million03/07/2025GBX 8GBX 8GBX 8GBX 7.60217,783 shs£7.52 million03/06/2025GBX 7.55GBX 8+5.96%GBX 8GBX 7.20895,039 shs£7.52 million03/05/2025GBX 7.50GBX 7.55+0.67%GBX 7.70GBX 7.30295,482 shs£7.10 million03/04/2025GBX 7.50GBX 7.50GBX 7.64GBX 7.50780,712 shs£7.05 million03/03/2025GBX 8GBX 7.50-6.25%GBX 8GBX 7.251.39 million shs£7.05 million02/28/2025GBX 8.50GBX 8-5.88%GBX 8.50GBX 7.50412,332 shs£7.52 million Related Companies Arecor Therapeutics Stock Price Chart OptiBiotix Health Stock Price Chart Poolbeg Pharma Stock Price Chart Sareum Stock Price Chart ImmuPharma Stock Price Chart Oxford BioDynamics Stock Price Chart IXICO Stock Price Chart Synairgen Stock Price Chart Hemogenyx Pharmaceuticals Stock Price Chart Cizzle Biotechnology Stock Price Chart Receive FAB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Fusion Antibodies and its competitors with MarketBeat's FREE daily newsletter. This page (LON:FAB) was last updated on 4/1/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredNew “Trump” currency proposed in DCA former U.S. Presidential Advisor has come forward with a stern warning to investors: “Get out of tech, no...Paradigm Press | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredHuge Elon-backed AI rollout begins – buy these nine stocksIf you suspect Elon Musk has an ulterior motive for coming to Washington, D.C.... You're 100% correct. ...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fusion Antibodies plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Fusion Antibodies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
